ZLAB - Zai Lab Ltd logo

Zai Lab Ltd

ZLAB

Zai Lab Ltd develops and commercializes biopharmaceutical products targeting oncology, immunology, neuroscience, and infectious diseases, with key offerings including Zejula for ovarian cancer and VYVGART for autoimmune conditions.

โš•๏ธ Healthcare NASDAQ Listed 2017 $ USD
$1,000 invested 5 years ago โ†’$239today

Score Overview

1 Year
Score
Net Growth-7.22%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-2.29%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score7.1
Net Growth73.28%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth211.56%
Rev Trend80%
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-273.56%
Net Trend44%
Net Income Consistency
Rev Growthโ€”
Rev Trend86%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Zai Lab Ltd has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. ZLAB does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 24.03โ€”
1 Year2025-10-23
$ 28.02-14.24%
5 Years2021-10-22
$ 100.75-76.15%
All Time2017-09-20
$ 27.93-13.96%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 449M-$ 188M$ 617M
2025$ 460M-$ 175M$ 689M
2024$ 398M-$ 257M$ 779M
2023$ 266M-$ 334M$ 806M
2022$ 215M-$ 443M$ 1.00B
2021$ 144M-$ 704M$ 1.40B
2020$ 48M-$ 268M$ 1.18B
2019$ 12M-$ 183M$ 275M
2018-$ 139M$ 263M
IPO2017$ 0.00-$ 50M$ 229M
ZLAB - Zai Lab Ltd logo

Zai Lab Ltd fundamental performance

Between 2020 and 2025, revenue grew from $ 48M to $ 460M and net income went from -$ 268M to -$ 175M. Revenue increased in 4 of those 5 years; net income in 4.

Zai Lab Ltd currently holds a 5-year HDB Score of 7.1 out of 10. How the HDB Score is calculated.

Membership

Explore ZLAB with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies